Sotera Health (NASDAQ:SHC) Hits New 52-Week High – Should You Buy?

Sotera Health Company (NASDAQ:SHC) shares reached a new 52-week high during trading on Monday . The stock traded as high as $16.69 and last traded at $16.74, with a volume of 131620 shares trading hands. The stock had previously closed at $16.16.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Barclays increased their price objective on Sotera Health from $17.00 to $19.00 and gave the stock an “overweight” rating in a research report on Thursday, October 2nd. Weiss Ratings reiterated a “sell (d)” rating on shares of Sotera Health in a research note on Wednesday, October 8th. Finally, Wall Street Zen raised shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 16th. Four research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $17.20.

Sotera Health Stock Down 0.5%

The company has a current ratio of 2.47, a quick ratio of 2.23 and a debt-to-equity ratio of 4.49. The firm has a 50 day moving average price of $16.02 and a 200-day moving average price of $13.23. The firm has a market cap of $4.72 billion, a price-to-earnings ratio of 207.78 and a beta of 1.82.

Sotera Health (NASDAQ:SHC) last posted its earnings results on Friday, August 8th. The company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.03. The firm had revenue of $294.34 million during the quarter, compared to the consensus estimate of $275.81 million. Sotera Health had a net margin of 2.14% and a return on equity of 39.42%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period last year, the firm posted $0.19 EPS. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. On average, equities analysts forecast that Sotera Health Company will post 0.61 EPS for the current year.

Insider Transactions at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 8,000,000 shares of Sotera Health stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $15.11, for a total transaction of $120,880,000.00. Following the completion of the transaction, the director directly owned 41,215,301 shares in the company, valued at $622,763,198.11. The trade was a 16.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Michael P. Rutz sold 126,611 shares of the company’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $16.38, for a total value of $2,073,888.18. Following the completion of the sale, the insider directly owned 450,204 shares in the company, valued at approximately $7,374,341.52. The trade was a 21.95% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 20,126,611 shares of company stock valued at $304,273,888 in the last ninety days. Corporate insiders own 55.12% of the company’s stock.

Institutional Trading of Sotera Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SHC. Ethic Inc. raised its stake in Sotera Health by 20.4% in the 3rd quarter. Ethic Inc. now owns 13,849 shares of the company’s stock valued at $218,000 after purchasing an additional 2,351 shares during the last quarter. CWM LLC grew its holdings in shares of Sotera Health by 194.6% during the third quarter. CWM LLC now owns 5,191 shares of the company’s stock worth $82,000 after buying an additional 3,429 shares in the last quarter. Pacer Advisors Inc. acquired a new position in shares of Sotera Health in the third quarter valued at approximately $365,000. Yousif Capital Management LLC lifted its stake in shares of Sotera Health by 5.2% during the third quarter. Yousif Capital Management LLC now owns 55,833 shares of the company’s stock valued at $878,000 after buying an additional 2,779 shares during the period. Finally, Farther Finance Advisors LLC lifted its stake in shares of Sotera Health by 16.0% during the third quarter. Farther Finance Advisors LLC now owns 11,434 shares of the company’s stock valued at $180,000 after buying an additional 1,573 shares during the period. Hedge funds and other institutional investors own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.